Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Non-Current Debt (2020)

Maxcyte (MXCT) has disclosed Non-Current Debt for 1 consecutive years, with $4.9 million as the latest value for Q4 2020.

  • Quarterly Non-Current Debt changed N/A to $4.9 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $4.9 million through Dec 2020, changed N/A year-over-year, with the annual reading at $4.9 million for FY2020, N/A changed from the prior year.
  • Non-Current Debt for Q4 2020 was $4.9 million at Maxcyte.
  • The five-year high for Non-Current Debt was $4.9 million in Q4 2020, with the low at $4.9 million in Q4 2020.